StockDuty ← Dashboard Nov 15, 2026 03:50 PM ET
SignalCorporate

3 British AI Stocks With Revenue Up To £4.7b

High-priority alert based on source significance and keyword relevance.

What happened: An article profiles three UK listed companies using AI in healthcare: Renalytix (AIM:RENX), Haleon (LSE:HLN) and AstraZeneca (LSE:AZN), citing geopolitical risk and supply chain pressure as drivers of automation and AI adoption. Key numbers: Renalytix records about $3 Why it matters: Haleon cites £800m in gross cost savings, 27% SKU and 26% formulation reductions, and AI tools improving forecast accuracy by 5 to 6%, underpinning a 140 basis points gross margin expansion. AstraZeneca's narrative cites 12 programs each with risk adjusted peak sales potential above US$5b. Market: +0.0% today ($184.45), +1.8% YTD, 0.6x vol — as of 23:47 UTC Coverage: 7 outlets in 24h
An article profiles three UK listed companies using AI in healthcare: Renalytix (AIM:RENX), Haleon (LSE:HLN) and AstraZeneca (LSE:AZN), citing geopolitical risk and supply chain pressure as drivers of automation and AI adoption.
Haleon cites £800m in gross cost savings, 27% SKU and 26% formulation reductions, and AI tools improving forecast accuracy by 5 to 6%, underpinning a 140 basis points gross margin expansion. AstraZeneca's narrative cites 12 programs each with risk adjusted peak sales potential above US$5b. Market: +0.0% today ($184.45), +1.8% YTD, 0.6x vol — as of 23:47 UTC
Sources